Medical Technology Firm
Monitored H.R. 3630: Temporary Payroll Tax Cut Continuation Act as it relates to Medicare reimbursement for Part B drugs. Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to a regulatory pathway for biosimilars and opposing efforts in the President's Budget to alter that pathway.
Education about reforming the Risk Evaluation and Mitigation Strategies provision in the FDA in the FDA Administration and Amendments Act of 2007 with respect to the upcoming Prescription Drug User Fee Act Reauthorization for FY 2013-2017.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX